
Sign up to save your podcasts
Or
In this episode of the THE Connect podcast, produced in partnership with the University of Liverpool, host Alistair Lawrence speaks with Shampa Das, professor of antimicrobial therapeutics, Reecha Sofat, Breckenridge chair of clinical pharmacology, and Paul O’Neill, professor of chemistry at the University of Liverpool.
They discuss the university's Therapeutics Innovation Frontier, a platform designed to deliver new therapies and improve existing ones for the benefit of patients locally, nationally and globally.
In this episode of the THE Connect podcast, produced in partnership with the University of Liverpool, host Alistair Lawrence speaks with Shampa Das, professor of antimicrobial therapeutics, Reecha Sofat, Breckenridge chair of clinical pharmacology, and Paul O’Neill, professor of chemistry at the University of Liverpool.
They discuss the university's Therapeutics Innovation Frontier, a platform designed to deliver new therapies and improve existing ones for the benefit of patients locally, nationally and globally.